Cargando…
Mutational analysis of Polycomb genes in solid tumours identifies PHC3 amplification as a possible cancer-driving genetic alteration
BACKGROUND: Polycomb group genes (PcGs) are epigenetic effectors implicated in most cancer hallmarks. The mutational status of all PcGs has never been systematically assessed in solid tumours. METHODS: We conducted a multi-step analysis on publically available databases and patient samples to identi...
Autores principales: | Crea, F, Sun, L, Pikor, L, Frumento, P, Lam, W L, Helgason, C D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776977/ https://www.ncbi.nlm.nih.gov/pubmed/23942079 http://dx.doi.org/10.1038/bjc.2013.454 |
Ejemplares similares
-
Clinical significance of Polycomb gene expression in brain tumors
por: Crea, Francesco, et al.
Publicado: (2010) -
Polycomb-mediated silencing in neuroendocrine prostate cancer
por: Clermont, Pier-Luc, et al.
Publicado: (2015) -
Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role
por: Clermont, P-L, et al.
Publicado: (2014) -
PhcA and PhcR Regulate Ralsolamycin Biosynthesis Oppositely in Ralstonia solanacearum
por: Li, Peng, et al.
Publicado: (2022) -
PHC: the future of oncology drug development
por: Yao, Yihong
Publicado: (2012)